Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesTransplantCommunity Health Plan Washington Transplant Prior …
    Ask Trek AI about this page
    CurrentCommunity Health Plan WashingtonPolicy MC.CP.MP.247

    Transplant Service Documentation Requirements

    Customize your policy alerts

    Sign up for Community Health Plan Washington Policy MC.CP.MP.247 alerts

    Get alerted when Policy MC.CP.MP.247 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Documentation and prior-authorization requirements for pre‑transplant evaluation, transplant listing, and post‑transplant follow-up for solid organ and stem cell transplants; applies to providers requesting transplant-related services from the health plan.

    Policy Summary
    PayerCommunity Health Plan Washington
    PolicyTransplant Service Documentation Requirements
    Policy CodePolicy MC.CP.MP.247
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionSubmit a prior authorization form with the required clinical documentation (H&P, labs, organ‑specific testing, infectious disease screening, psychosocial evaluation and drug screen) according to request type.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    10required documentation items for transplant evaluation
    12 mo

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    authorization efficacy (listing)
    6 moauthorization efficacy (evaluation)
    90 ddrug screen recency
    12 moclinical assessments recency

    Medical Necessity & Coverage Criteria

    Documentation-based medical necessity criteria

    Requests are medically necessary when ALL of the following documentation elements are provided according to request type:

    Transplant evaluation requirements (I.A): For transplant evaluation requests include: 1) appropriate prior authorization form; 2) complete history and physical within one year including history of present illness, list of current medications, past medical history, pertinent family and social history, complete review of systems, and physical exam including height, weight and BMI. Approved evaluation authorizations are effective for six months.

    Applies to stem cell and solid organ transplant evaluations

    Initial and subsequent transplant listing requirements (I.B): For initial and subsequent transplant listing requests include: 1) appropriate prior authorization form; 2) letter of medical necessity from a transplant service provider with signature; 3) complete history and physical by a transplant service provider within 12 months (history of present illness including current medications; past medical, family, and social history; review of systems; physical exam including height, weight, BMI); 4) complete chemistry panel/liver function tests and complete blood count within 12 months; 5) appropriate organ-specific testing, imaging, and documentation (liver: INR, MELD/PELD score and liver biopsy as indicated; kidney: GFR or creatinine clearance if not on dialysis; heart: echocardiogram, right heart catheterization including pulmonary vascular resistance, NYHA class and peak VO2; lung: pulmonary function tests, chest x-ray and/or CT imaging, and six-minute walk test); 6) annual dental evaluation and clearance; 7) routine health screening exams per standards of care; 8) appropriate comorbidity testing/clearance including cardiology; 9) serum or urine drug screen within 90 days of request; 10) infectious disease screening (CMV and VZV within one year unless IgG antibody positive; EBV within one year unless IgG positive; toxoplasma titer for heart recipients; PPD/T‑Spot/QuantiFERON within one year unless previously positive; hepatitis B and C within one year unless baseline antibody positive with viral load if baseline positive; RPR within one year; HIV within one year unless baseline positive with CD4 and viral load if positive); 11) detailed psychosocial evaluation and clearance within 12 months. Approved listing authorizations are effective for 12 months.

    Includes organ-specific items

    Post-transplant follow-up visits (I.C): For post-transplant follow-up office visit authorization include: 1) appropriate prior authorization form; and 2) discharge summary or history and physical from the inpatient transplant admission. (Inpatient transplant admissions require separate authorization.)

    Separate authorizations apply for transplant admissions

    This policy's documentation requirements apply to solid organ and hematopoietic stem cell transplant requests and do not apply to certain other transplant types. Specifically, documentation requirements in this policy do not apply to corneal transplant, pancreatic islet cell auto‑transplant after pancreatectomy, or parathyroid auto‑transplant after thyroidectomy. For those procedures, providers must complete the Health Plan–specific prior authorization form as noted on the Health Plan website.

    Coding & Test Recency

    Referenced coding guidancemixed
    CPT ® (referenced)CPT codes referenced in policy for informational purposes; specific codes not enumerated in the document.
    inv-04: Drug screen recency — maximum age for required drug screen prior to request
    Maximum age for required drug screenSerum or urine drug screen results must be within 90 days of the request.
    Applies toInitial listing and evaluation requests as part of required documentation for transplant listing.
    Exceptions/notesNo exception noted for positive baseline; follow plan guidance for interpretation and documentation.
    inv-05: Clinical assessments recency — most clinical assessments required within
    Recency requirementMost clinical assessments (e.g., complete history and physical, chemistry panel/liver function tests, CBC, organ‑specific testing, infectious disease screening, psychosocial evaluation) must be current within 12 months of the evaluation or listing request.
    Examples of assessments

    Prior Authorization & Provider Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for transplant evaluations, transplant listings, and post‑transplant follow‑up office visits. Approved evaluation authorizations are effective for six months; approved transplant listing authorizations are effective for 12 months. Inpatient transplant admissions require a separate authorization.

    • Evaluation authorizations effective period: 6 months
    • Listing authorizations effective period: 12 months
    • Inpatient transplant admissions require separate authorization
    Note

    Multiple facilities / Additional evaluations

    Authorizations for services at multiple facilities or for additional evaluations after a transplant listing or prior evaluation approval are allowed when medically necessary. Examples include a change in transplant eligibility due to an intervening illness, or admission to a geographically closer facility when the member is not stable for transfer to the previously approved facility.

    • Medically necessary when: member has an episode of illness changing eligibility

    Background & Rationale

    The purpose of the pre‑transplant evaluation is to identify conditions that can affect a candidate's ability to achieve a successful transplant and tolerate surgery and postoperative recovery. The evaluation assesses overall health, disease stage, infectious risk, comorbidities, and biologic compatibility to determine transplant candidacy. The policy bases its documentation expectations on established guidance (KDIGO, ISHLT, UNOS) and requires many clinical assessments to be current (generally within 12 months) to ensure decisions reflect accurate, up‑to‑date clinical data.

    Key Definitions

    inv-11: Pre-transplant evaluation definition — clinical workup including diagnostic tests and consultations necessary to assess transplant candidacy
    DefinitionThe pre-transplant evaluation is the clinical workup including diagnostic tests and consultations necessary to assess transplant candidacy and identify conditions that may affect surgery or postoperative recovery.
    Core componentsComplete history and physical; organ‑specific testing and imaging; laboratory panels and infectious disease screening; psychosocial evaluation; comorbidity clearances and specialist consultations as indicated.
    PurposeIdentify conditions that affect transplant success and determine medical necessity based on clinical data and indicators of surgical or postoperative risk.

    Organ-specific Candidate Testing & Criteria

    Organ-specific candidate testing

    Organ-specific testing and documentation required for listing requests:

    Liver: INR, MELD or PELD score and liver biopsy as indicated; complete chemistry/liver function tests and complete blood count within 12 months.

    References UNOS MELD/PELD guidance

    Kidney: Glomerular filtration rate (GFR) or creatinine clearance if not on dialysis; complete chemistry panel within 12 months.

    References KDIGO guidance

    Heart: Echocardiogram; right heart (cardiac) catheterization results including pulmonary vascular resistance (PVR); documentation of NYHA class and peak VO2 results.

    References ISHLT/UNOS guidance

    Contraindications & Exclusions

    This policy emphasizes identifying conditions that would complicate surgery or adversely affect postoperative recovery and outcomes. While the document does not enumerate an exhaustive list of absolute or relative contraindications, it directs reviewers and clinicians to derive specific contraindications from the cited clinical guidelines (KDIGO, ISHLT, UNOS). In practice, contraindications are those medical or psychosocial conditions that materially increase perioperative risk or undermine the benefits of transplantation and should be documented and considered during the evaluation.

    Pre-Transplant Evaluation Requirements

    Note

    Complete evaluation requires H&P, labs, organ‑specific testing, infectious disease screening, dental and psychosocial clearance

    A comprehensive pre‑transplant evaluation must include a complete history and physical, appropriate laboratory testing, organ‑specific testing/imaging, infectious disease screening, dental clearance, routine preventive screenings, comorbidity testing/clearance, serum or urine drug screen, and a detailed psychosocial evaluation; many items must be current (generally within 12 months, drug screen within 90 days).

    • Complete history and physical (H&P) within one year including HPI, medication list, past medical, family and social history, ROS, and physical exam with height/weight/BMI
    • Complete chemistry panel/liver function tests and CBC within 12 months
    • Organ‑specific testing (e.g., INR/MELD for liver; GFR/creatinine clearance for kidney; echocardiogram/right heart cath/peak VO2 for heart; PFTs and six‑minute walk for lung)
    • Annual dental evaluation/clearance
    • Infectious disease screening per policy (CMV, VZV, EBV, toxoplasma for heart, PPD/T‑Spot/QuantiFERON, hepatitis B and C, RPR, HIV with follow‑up testing if positive)
    • Serum or urine drug screen within 90 days
    • Detailed psychosocial evaluation within 12 months

    Transplant Center & Facility Requirements

    Note

    Use participating facilities and follow prior authorization processes; inpatient admissions need separate authorization

    Transplants must occur at a participating facility and authorizations for transplant evaluations, listings, and post‑transplant follow‑up are processed per the health plan's prior authorization requirements; inpatient transplant admissions require a separate authorization from evaluation or listing authorizations.

    Post-Transplant Follow-up Coverage

    inv-16: Post-transplant office visits — Authorizations require prior authorization and inpatient discharge summary or H&P; inpatient transplant documentation required
    Authorization requirementPost-transplant follow-up office visit authorizations require a prior authorization form.
    Required inpatient documentationAuthorization requests must include the inpatient discharge summary or the history and physical from the transplant admission.
    Separate admissions authorizationInpatient transplant admissions require separate prior authorization from evaluation, listing, or post‑transplant office visit authorizations.
    Policy Summary
    PayerCommunity Health Plan Washington
    PolicyTransplant Service Documentation Requirements
    Policy CodePolicy MC.CP.MP.247
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionSubmit a prior authorization form with the required clinical documentation (H&P, labs, organ‑specific testing, infectious disease screening, psychosocial evaluation and drug screen) according to request type.
    SourceLink
    On This Page
    Medical Necessity & Coverage CriteriaCoding & Test RecencyPrior Authorization & Provider RequirementsBackground & RationaleKey DefinitionsOrgan-specific Candidate Testing & CriteriaContraindications & ExclusionsPre-Transplant Evaluation RequirementsTransplant Center & Facility RequirementsPost-Transplant Follow-up Coverage
    Complete H&P within one year; CBC and chemistry/liver function tests within 12 months; infectious disease tests (CMV, VZV, EBV, hepatitis, RPR, HIV), and psychosocial evaluation within 12 months.
    RationaleEnsures accurate, current clinical data to assess transplant candidacy per KDIGO, ISHLT, and UNOS guidance.
  1. Medically necessary when: member admitted to closer facility and not stable for transfer
  2. Documentation Required

    Required documentation

    Providers must submit the appropriate prior authorization form plus the required clinical documentation specific to the type of request (evaluation, initial/subsequent listing, post‑transplant follow‑up, or continuity of care). See the detailed documentation list below.

    • Evaluation requests: prior authorization form; complete history & physical within 1 year (history of present illness with current meds, past medical/family/social history, review of systems, physical exam including height, weight, BMI)
    • Listing requests (initial/subsequent): prior authorization form; signed letter of medical necessity from transplant service provider; complete H&P by transplant service provider within 12 months (history of present illness with current meds; past/family/social history; review of systems; physical exam incl. height, weight, BMI); complete chemistry panel/liver function tests and CBC within 12 months; appropriate testing/imaging/documentation specific to organ (e.g., liver: INR, MELD/PELD, biopsy as indicated; kidney: GFR or creatinine clearance if not on dialysis; heart: echo, right heart cath including PVR, NYHA class, peak VO2; lung: PFTs, chest imaging, six‑minute walk test); annual dental evaluation/clearance; routine preventive screening per standards of care; appropriate comorbidity testing/clearance (including cardiology); serum or urine drug screen within 90 days; infectious disease screening as specified; detailed psychosocial evaluation within 12 months
    Denial Risk

    Missing or expired documentation — impact

    Requests missing required documentation or with expired documentation will be impacted per policy. Examples include missing prior authorization form, missing or outdated H&P, expired labs or infection screening, absent drug screen, or missing dental/psychosocial clearances. Continuity of care requests must include documentation of previous insurer coverage, prior authorization by the previous insurer, and a copy of the UNOS listing.

    • Missing or expired items may require resubmission or new authorization: prior authorization form, H&P, labs, infection screening, drug screen, dental or psychosocial evaluation
    • Continuity of care requirements: documentation of previous insurer coverage; documentation of prior authorization by previous insurer; copy of UNOS listing
    Lung: Pulmonary function tests; chest x-ray and/or CT imaging; six-minute walk test.

    References ISHLT consensus